Pages that link to "Q37374917"
Jump to navigation
Jump to search
The following pages link to Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumors (Q37374917):
Displaying 14 items.
- An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma (Q26784091) (← links)
- High-frequency aberrantly methylated targets in pancreatic adenocarcinoma identified via global DNA methylation analysis using methylCap-seq. (Q34254966) (← links)
- Profiles of cancer stem cell subpopulations in cholangiocarcinomas. (Q35669078) (← links)
- Molecular Targets in Biliary Carcinogenesis and Implications for Therapy (Q35820533) (← links)
- Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract. (Q37497846) (← links)
- Molecular pathogenesis of intrahepatic cholangiocarcinoma (Q38244965) (← links)
- The role of polycomb repressive complexes in biliary tract cancer. (Q38271374) (← links)
- Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets (Q39120148) (← links)
- Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma (Q39330528) (← links)
- DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype (Q61865585) (← links)
- Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases (Q64067034) (← links)
- Significant association of EED promoter hypomethylation with colorectal cancer (Q92683989) (← links)
- Epigenome Remodeling in Cholangiocarcinoma (Q92821362) (← links)
- Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - The promise of DNA methylation and molecular biomarkers (Q99558400) (← links)